Efficacy of cilostazol in canine bradyarrhythmia
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Veterinary Science"
DOI: 10.3389/fvets.2022.954295
Abstract: Recently, cilostazol, a phosphodiesterase III inhibitor, has been described as alternative medical treatment for canine bradyarrhythmia in cases for which pacemaker implantation was not indicated or available. In this retrospective study, we investigated the use… read more here.
Keywords: efficacy; bradyarrhythmia; efficacy cilostazol; canine bradyarrhythmia ... See more keywords